MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 134 filers reported holding MACROGENICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,895,657 | -26.8% | 1,050,570 | -16.0% | 0.00% | 0.0% |
| Q2 2023 | $6,687,457 | +360.9% | 1,249,992 | +517.8% | 0.00% | – |
| Q1 2023 | $1,451,000 | +91503.5% | 202,342 | -14.3% | 0.00% | – |
| Q4 2022 | $1,584 | -99.9% | 236,097 | -28.3% | 0.00% | – |
| Q3 2022 | $1,140,000 | -3.2% | 329,456 | -17.4% | 0.00% | – |
| Q2 2022 | $1,178,000 | -52.9% | 399,054 | +40.6% | 0.00% | – |
| Q1 2022 | $2,500,000 | +62.1% | 283,760 | +195.5% | 0.00% | – |
| Q4 2021 | $1,542,000 | -26.9% | 96,036 | -4.7% | 0.00% | – |
| Q3 2021 | $2,109,000 | -27.5% | 100,727 | -7.0% | 0.00% | – |
| Q2 2021 | $2,909,000 | +175.2% | 108,300 | +226.3% | 0.00% | – |
| Q1 2021 | $1,057,000 | -58.2% | 33,188 | -70.0% | 0.00% | – |
| Q4 2020 | $2,530,000 | +410.1% | 110,683 | +462.4% | 0.00% | – |
| Q3 2020 | $496,000 | +10.2% | 19,681 | +22.1% | 0.00% | – |
| Q2 2020 | $450,000 | +394.5% | 16,123 | +3.1% | 0.00% | – |
| Q1 2020 | $91,000 | -46.5% | 15,641 | +0.1% | 0.00% | – |
| Q4 2019 | $170,000 | -14.6% | 15,626 | 0.0% | 0.00% | – |
| Q3 2019 | $199,000 | -55.6% | 15,626 | -41.9% | 0.00% | – |
| Q2 2019 | $448,000 | +160.5% | 26,886 | +181.1% | 0.00% | – |
| Q1 2019 | $172,000 | -55.7% | 9,564 | -68.7% | 0.00% | – |
| Q4 2018 | $388,000 | +10.9% | 30,603 | +87.6% | 0.00% | – |
| Q3 2018 | $350,000 | -13.6% | 16,311 | -16.7% | 0.00% | – |
| Q2 2018 | $405,000 | -50.1% | 19,586 | -39.3% | 0.00% | – |
| Q1 2018 | $812,000 | +63.7% | 32,262 | +23.7% | 0.00% | – |
| Q4 2017 | $496,000 | +38.2% | 26,084 | +33.9% | 0.00% | – |
| Q3 2017 | $359,000 | +1.1% | 19,475 | -3.9% | 0.00% | – |
| Q2 2017 | $355,000 | -78.1% | 20,275 | -76.8% | 0.00% | – |
| Q1 2017 | $1,623,000 | -19.5% | 87,250 | -11.5% | 0.00% | – |
| Q4 2016 | $2,015,000 | -36.0% | 98,600 | -6.3% | 0.00% | -100.0% |
| Q3 2016 | $3,147,000 | -46.7% | 105,227 | -51.9% | 0.00% | 0.0% |
| Q2 2016 | $5,908,000 | +92.3% | 218,891 | +33.6% | 0.00% | 0.0% |
| Q1 2016 | $3,073,000 | -39.5% | 163,866 | -0.1% | 0.00% | 0.0% |
| Q4 2015 | $5,078,000 | +28.7% | 163,950 | -11.0% | 0.00% | 0.0% |
| Q3 2015 | $3,946,000 | -46.2% | 184,225 | -4.6% | 0.00% | -50.0% |
| Q2 2015 | $7,330,000 | -15.4% | 193,050 | -30.1% | 0.00% | 0.0% |
| Q1 2015 | $8,664,000 | +32.1% | 276,192 | +47.7% | 0.00% | +100.0% |
| Q4 2014 | $6,557,000 | +68.5% | 186,971 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $3,891,000 | -4.5% | 186,175 | -0.7% | 0.00% | 0.0% |
| Q2 2014 | $4,073,000 | -39.4% | 187,450 | -22.4% | 0.00% | -50.0% |
| Q1 2014 | $6,723,000 | +103.5% | 241,550 | +100.6% | 0.00% | +100.0% |
| Q4 2013 | $3,303,000 | – | 120,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |